Tribune Pulse - January 17 - 2018 Late Breaker Abstarct Submission now Open!

Webinar Liver Series Webinar, Transplantation Journal featured Article, Sandy Feng January 24 Webinar, In the News and more.

Email not displaying correctly? View it in your browser. TTS 2018 is now considering abstracts in the late-breaker and poster categories until FEBRUARY 15.  It is anticipated that the compilation of late breaker abstracts is made possible by studies completed after the initial November 15, 2017 abstract submission deadline. They are intended to represent the very latest development in transplantation science. These abstracts will be reviewed in a very finite period by a special review board, and accepted with the same stringent criteria as the Nov 2017 abstract submissions. The review criteria will be at par with the original call for abstracts in Nov 2017, but for late-breaking abstracts there will be a stronger focus on the criteria of "very latest development in the field of transplantation". Click here for details and to submit   Friday, January 19 Liver Series Webinar   Discussant: Laura J. Wozniak, MD Assistant Clinical Professor of Pediatrics in the Division of Gastroenterology, Hepatology, and Nutrition UCLA, USA     Discussant: Jacqueline O'Leary, MD, MPH Medical Director of Research Baylor Simmons TransplantInstitute, Dallas, USA     Click here to signup Date and time: January 19th, 2018 2:00 PM EST (UTC-5 hours) Topic: Antibody Mediated Rejection in Liver Transplantation Part I - Role of DSA's and Treatment Options Description: Antibody mediated rejection (AMR) has become one of the hot topics in liver transplantation recently. In this webinar, world known experts in this topic will discuss the immunological, clinical aspects of AMR as well as available treatment options. Format: Debate/Discussion   ALERT ...  Upcoming Member Poll on 2022 Congress Venue TTS Members will receive an email on January 22 asking for their opinion on the location of the 2022 Congress. Keep an eye out for the email! FEATURED ARTICLE - Transplantation Submitted by Dr Karen Keung, Editorial Fellow, Transplantation.  DHRS9 Is a Stable Marker of Human Regulatory Macrophages. Riquelme P, Amodio G, Macedo C, et al. Transplantation. 2017 ;101(11):2731-2738. Cellular therapy using human regulatory macrophages (Mregs) to promote immune regulation is under evaluation in early phase clinical trials in kidney transplantation. In this study, the authors aimed to define a novel positive markers of human Mregs. A series of monoclonal antibodies (mAb) was generated by vaccinating mice with human Mreg lysates. A mAb clone (ASOT1) was found to react strongly with Mregs; immunoprecipitation and MALDI-MS sequencing identified dehydrogenase/reductase 9 (DHRS9) as the antigen. DHRS9 appeared as a promising specific and stable marker of human Mregs discriminating human Mregs from a panel of in vitro- derived macrophages in other polarization states. Read the article Webinar Announcement Quality Assessment of Kidneys for Transplantation – Truth or Dare Wednesday, January 24, 2018 - 12pm EST  (9am San Francisco / 3pm Rio de Janeiro)    Speaker: Professor Sandy Feng, MD, PhD  Professor of Surgery in Residence Director, Abdominal Transplant Surgery Fellowship University of California San Franciscos     Moderator: Professor Eduardo Rocha, MD, PhD  Professor of Nephrology Universidade Federal do Rio de Janeiro Rio de Janeiro, Brazil     Click here to signup Overview: The demand for kidney transplantation continues to rise inexorably as its life-saving and life-enhancing benefits are strongly established. The supply of kidneys remains sorely inadequate both in quantity and, very importantly, quality. These two factors combine to exert tremendous pressure to accomplish transplantation by aggressively utilizing all available deceased donor organs. This webinar will consider donor, recipient, transplant, and other relevant factors, as well as their potential interplay, that enter into the critical decision of whether to transplant or not to transplant.   Newly FDA-Approved Platform Will Rapidly "Manufacture" Stem Cells to Repair Our Bodies This Doctor's Revolutionary Stem Cell Treatments Could Eradicate HIV St. Jude Develops Gene Therapy for Severe Combined Immunodeficiency Unraveling the Biocircuitry of Obesity Follow us on Social Media       About Us The Transplantation Society is the leading NGO promoting and fostering education in transplantation around the world. Read More   Subscription Update Email Address Unsubscribe   Share Forward to a Friend © The Transplantation Society - www.tts.org T: +1 514-874-1717 | E: pulse@tts.org This newsletter was sent to Gustavo Braslavsky at gustavo.braslavsky@gmail.com Rather not receive it anymore? Unsubscribe